BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9033246)

  • 21. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons from an audit of unplanned pregnancies.
    Metson D
    BMJ; 1988 Oct; 297(6653):904-6. PubMed ID: 3140975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined oral contraceptives: acceptability and effective use.
    Kubba A; Guillebaud J
    Br Med Bull; 1993 Jan; 49(1):140-57. PubMed ID: 8324604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics.
    Back DJ; Grimmer SF; Orme ML; Proudlove C; Mann RD; Breckenridge AM
    Br J Clin Pharmacol; 1988 May; 25(5):527-32. PubMed ID: 3408633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception.
    Christensen JT; Boldsen J; Westergaard JG
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):784-9. PubMed ID: 9348259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal study of contraception and pregnancy outcome in a representative sample of young Swedish women.
    Milsom I; Sundell G; Andersch B
    Contraception; 1991 Feb; 43(2):111-9. PubMed ID: 2040167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial.
    Little P; Griffin S; Kelly J; Dickson N; Sadler C
    BMJ; 1998 Jun; 316(7149):1948-52. PubMed ID: 9641933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions with oral contraceptives.
    Fotherby K
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2153-9. PubMed ID: 2256524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chronic oral contraceptive steroids on theophylline disposition.
    Tornatore KM; Kanarkowski R; McCarthy TL; Gardner MJ; Yurchak AM; Jusko WJ
    Eur J Clin Pharmacol; 1982; 23(2):129-34. PubMed ID: 7140802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of estrogens and progestogens on lipid metabolism.
    Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptives and antibiotics: important considerations for dental practice.
    Gibson J; McGowan DA
    Br Dent J; 1994 Dec 10-24; 177(11-12):419-22. PubMed ID: 7803151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.
    Orme ML
    Br J Clin Pharmacol; 1982 Jul; 14(1):31-42. PubMed ID: 7049209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.